CEACAM5 and pancreatic neoplasm: When combined as a 2-tsRNA signature to distinguish pancreatic cancer patients from healthy individuals, the area under the curve reached 0.94, significantly outperforming traditional carbohydrate antigen 19-9 and carcinoembryonic antigen serum biomarkers [12].